SAN DIEGO--(BUSINESS WIRE)--Apricus Biosciences, Inc., (“Apricus Bio”) (Nasdaq: APRI) today announced the formation of a Clinical Advisory Board focused on the development of its investigational oncology compound, PrevOnco™. The Clinical Advisory Board is chaired by Stephen B. Howell, who also serves as Chairman of the Company’s Scientific Advisory Board (“SAB”). Additional members of the Clinical Advisory Board include, Drs. Ghassan K. Abou-Alfa, Melanie Thomas, Robert G. Gish and Yehuda Patt.
